OpenURL Connection Search

Select item for more details and to access through your institution.

A phase 2 study of panitumumab with irinotecan as salvage therapy in chemorefractory KRAS exon 2 wild-type metastatic colorectal cancer patients.
Published in:
2019
By:
- Elez, Elena;
- Pericay, Carles;
- Valladares-Ayerbes, Manuel;
- Bando, Inmaculada;
- Safont, Maria Jose;
- Gallego, Javier;
- Grávalos, Cristina;
- Arrivi, Antonio;
- Carrato, Alfredo;
- Conde, Verónica;
- Ortiz, Maria José;
- López, Carlos;
- Alonso, Beatriz;
- Ruiz de Mena, Inmaculada;
- Díaz-Rubio, Eduardo;
- Tabernero, Josep;
- Aranda, Enrique
Publication type:
journal article
Correction to: A Phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients.
Published in:
2018
By:
- Alsina, Maria;
- Rivera, Fernando;
- Ramos, Francisco Javier;
- Galán, Maica;
- López, Rafael;
- García-Alfonso, Pilar;
- Alés-Martinez, José Enrique;
- Queralt, Bernardo;
- Antón, Antonio;
- Carrato, Alfredo;
- Grávalos, Cristina;
- Méndez-Vidal, Maria José;
- López, Carlos;
- de Mena, Inmaculada Ruiz;
- Tabernero, Josep;
- Giralt, Jordi;
- Aranda, Enrique;
- on behalf of the Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD) and Grupo de Investigación Clínica en Oncología Radioterápica (GICOR);
- Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD) and Grupo de Investigación Clínica en Oncología Radioterápica (GICOR)
Publication type:
journal article
A phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients.
Published in:
2018
By:
- Alsina, Maria;
- Rivera, Fernando;
- Ramos, Francisco Javier;
- Galán, Maica;
- López, Rafael;
- García-Alfonso, Pilar;
- Alés-Martinez, José Enrique;
- Queralt, Bernardo;
- Antón, Antonio;
- Carrato, Alfredo;
- Grávalos, Cristina;
- Méndez-Vidal, Maria José;
- López, Carlos;
- de Mena, Inmaculada Ruiz;
- Tabernero, Josep;
- Giralt, Jordi;
- Aranda, Enrique;
- on behalf of the Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD) and Grupo de Investigación Clínica en Oncología Radioterápica (GICOR);
- Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD) and Grupo de Investigación Clínica en Oncología Radioterápica (GICOR)
Publication type:
journal article
Single‐Agent Regorafenib in Metastatic Colorectal Cancer Patients with Any RAS or BRAF Mutation Previously Treated with FOLFOXIRI plus Bevacizumab (PREVIUM Trial).
Published in:
Oncologist, 2018, v. 23, n. 11, p. 1271, doi. 10.1634/theoncologist.2018-0316
By:
- García‐Alfonso, Pilar;
- Benavides, Manuel;
- Falcó, Esther;
- Muñoz, Andrés;
- Gómez, Auxiliadora;
- Sastre, Javier;
- Rivera, Fernando;
- Montagut, Clara;
- Salgado, Mercedes;
- López‐Ladrón, Amelia;
- López, Rafael;
- Ruiz de Mena, Inmaculada;
- Durán, Gema;
- Aranda, Enrique
Publication type:
Article

Found: 4

A phase 2 study of panitumumab with irinotecan as salvage therapy in chemorefractory KRAS exon 2 wild-type metastatic colorectal cancer patients.

Correction to: A Phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients.

A phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients.

Single‐Agent Regorafenib in Metastatic Colorectal Cancer Patients with Any RAS or BRAF Mutation Previously Treated with FOLFOXIRI plus Bevacizumab (PREVIUM Trial).